Impact46

Impact46 is a Riyadh-based innovation-driven asset management firm providing early and growth-stage capital to technology-enabled enterprises driving Saudi Arabia’s digital transformation. Stage focus spans seed through growth with checks in the $1M to $5M range and the capacity to participate in larger syndicates, and AI is a stated focus. Healthcare interest centers on digital health and healthcare software within a broader Vision 2030-aligned technology mandate. The fund’s positioning combines venture-style early-stage investing with growth-equity capacity and strong relationships across Saudi sovereign-aligned capital and family offices. The right founder for Impact46 is a Saudi-based or globally ambitious operator building a digital health, healthcare software, or healthcare AI business with credible Saudi-market wedge and clear Vision 2030 alignment, including health-sector privatization, NPHIES interoperability, mandatory health insurance expansion, or specific MOH or SFDA-relevant categories. The wrong founder is a deep medtech or therapeutics team needing scientific syndicate construction, a non-Saudi founder without a Saudi-market thesis, or a Series A-plus company looking for institutional lead outside MENA. Intro paths run through Riyadh’s institutional capital community including the PIF and Sanabil ecosystems, Monsha’at and the broader MISK affiliated networks, frequent co-investors and follow-on partners including STV, Wa’ed Ventures, Hala Ventures, Riyad Capital, and Suhail Ventures, and through Impact46’s existing portfolio CEOs many of whom are publicly active. Direct outreach is acknowledged but conversion is materially better through institutional referral or specific Saudi operator connections. In the pitch, lead with the Saudi-market wedge, real customer evidence including any anchor pilots with major private health groups or government contracts, and a credible Vision 2030 alignment narrative. Be specific about MOH, SFDA, NPHIES, and the mandatory health insurance regime, and about Saudization implications for hiring. Show clean unit economics, a defensible technical narrative including data and AI architecture if relevant, and a credible exit story tied to either Tadawul listing optionality or strategic acquisition by Saudi or regional health groups. Caveats include the inherent volatility of Saudi capital deployment which can be cyclical between fund vintages, the diligence depth that requires founders to come prepared with audit-ready data rooms, and the reality that Impact46’s check size positions the fund as a syndicate participant alongside larger institutional Saudi investors. For Saudi-aligned healthcare technology founders, Impact46 is a credible regional partner with sector-specific pattern recognition.